ArticleNucleic acids research2025
UVA-induced DNA damage and mutations in human melanocytes: relevance for melanoma mutations.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DeepPNI: a language- and graph-based model for mutation-driven protein-nucleic acid binding energetics.Nucleic acids research · 2026Article
- Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Article
- Dysregulation of the PATZ1/CTCF Balance Silences ZBTB20 to Drive Melanoma Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
UVB radiation (280-320 nm) from sunlight induces skin cancer through DNA damage-induced mutations. Melanomas carry mutational signatures associated with UVB-induced cyclobutane pyrimidine dimers (CPDs). However, there are several other melanoma signatures of unknown origin. To test if these signatures are linked to UVA, we exposed human melanocytes to UVA (340-400 nm) and to UVB for comparison. We mapped DNA damage in the form of CPDs or 8-oxoguanines (8-oxoG) genome-wide at base resolution. We then determined mutational patterns in single melanocyte cell clones by whole genome sequencing. Different from UVB, UVA induces CPDs more selectively at TT sequences resembling melanoma signature SBS7d. We did not observe rising CPD levels after cessation of radiation (dark CPDs). The UVA-induced CPDs were not mutagenic in the mutation analysis. 8-oxoG was present in melanocytes but did not substantially increase after UVA. G/C to T/A mutations were prominent in melanocyte single-cell clones with no major shift after UVA radiation. These mutations matched SBS18, a signature present in melanomas. Although UVA damages DNA, it has a surprisingly limited mutagenic effect on human melanocytes. However, the oxidative base lesions in melanocytes and their associated mutations may be linked to a subset of melanoma mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.